help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matta, S. G.
Right arrow Articles by Sharp, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matta, S. G.
Right arrow Articles by Sharp, B. M.

Endocrinology, Vol 127, 1646-1655, Copyright © 1990 by Endocrine Society


ARTICLES

Catecholamines mediate nicotine-induced adrenocorticotropin secretion via alpha-adrenergic receptors

SG Matta, J Singh and BM Sharp
Endocrine Neuroscience Laboratories, Minneapolis Medical Research Foundation, Minnesota.

Previous studies determined that iv nicotine stimulates ACTH secretion by acting on sites accessible from the fourth ventricle (IV), rather than directly on CRF-containing neurons in the hypothalamus. Brainstem catecholaminergic cell groups, which are accessible from the IV, project to the hypothalamus and stimulate the secretion of CRF and ACTH. Therefore, these studies investigated the role of catecholamines in nicotine-stimulated ACTH secretion. Experiments with the catecholaminergic neurotoxin, 6-hydroxydopamine, demonstrate that the ACTH response to nicotine delivered iv (0.03 or 0.05 mg/kg body wt) or instilled into the IV (1 or 2.5 micrograms) was significantly reduced in lesioned animals (P less than 0.01). Selective inhibitors of epinephrine synthesis, SKF 64139 and 2,3-dichloro-alpha- methylbenzylamine (DCMB), significantly reduced (P less than 0.01) the ACTH response to 0.05 mg/kg body wt nicotine iv, without affecting median eminence CRF content. Because controversy exists about the effect of DCMB as an alpha 2 adrenoreceptor antagonist in vivo, this was examined by administering norepinephrine into the third ventricle after DCMB ip; DCMB significantly reduced the ACTH response to norepinephrine 0.2 micrograms (P less than 0.05) but not to 0.5 micrograms. To determine whether alpha 2 receptors are indeed involved in the ACTH response to nicotine, yohimbine, an alpha 2 antagonist, was injected into the third ventricle before nicotine injection into the IV. Yohimbine significantly reduced the ACTH response. Thus, the secretion of both hypothalamic epinephrine and, to some extent, norepinephrine is involved in the ACTH response to the activation of catecholaminergic neurons in the IV. Further investigation of the adrenergic receptor(s) involved compared the ACTH response to nicotine (1 microgram) instilled into the IV after prazocin (alpha 1 antagonist), or propranolol (beta antagonist) was injected into the third ventricle. Prazocin significantly reduced (P less than 0.05) the ACTH response, whereas propranolol was ineffective. Thus, both alpha 1 and alpha 2 receptors are involved in mediating the ACTH response to nicotine.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
R. Zhao, H. Chen, and B. M. Sharp
Nicotine-Induced Norepinephrine Release in Hypothalamic Paraventricular Nucleus and Amygdala Is Mediated by N-Methyl-D-aspartate Receptors and Nitric Oxide in the Nucleus Tractus Solitarius
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 837 - 844.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
A. M. Rasmusson, M. R. Picciotto, and S. Krishnan-Sarin
Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review
J Psychopharmacol, September 1, 2006; 20(5): 693 - 707.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. E. Myles, A. M. Azcuy, N. T. Nguyen, E. R. Reisch, S. A. Barker, H. W. Thompson, and J. M. Hill
Bupropion (Zyban, Wellbutrin) Inhibits Nicotine-Induced Viral Reactivation in Herpes Simplex Virus Type 1 Latent Rabbits
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 640 - 644.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Fu, S. G. Matta, V. G. Brower, and B. M. Sharp
Norepinephrine Secretion in the Hypothalamic Paraventricular Nucleus of Rats during Unlimited Access to Self-Administered Nicotine: An In Vivo Microdialysis Study
J. Neurosci., November 15, 2001; 21(22): 8979 - 8989.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D.-K. SONG, Y.-B. IM, J.-S. JUNG, H.-W. SUH, S.-O. HUH, J.-H. SONG, and Y.-H. KIM
Central injection of nicotine increases hepatic and splenic interleukin 6 (IL-6) mRNA expression and plasma IL-6 levels in mice: involvement of the peripheral sympathetic nervous system
FASEB J, July 1, 1999; 13(10): 1259 - 1267.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. W. Wuenschell, J. Zhao, J. D. Tefft, and D. Warburton
Nicotine stimulates branching and expression of SP-A and SP-C mRNAs in embryonic mouse lung culture
Am J Physiol Lung Cell Mol Physiol, January 1, 1998; 274(1): L165 - L170.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Fu, S. G. Matta, J. D. Valentine, and B. M. Sharp
Adrenocorticotropin Response and Nicotine-Induced Norepinephrine Secretion in the Rat Paraventricular Nucleus Are Mediated through Brainstem Receptors
Endocrinology, May 1, 1997; 138(5): 1935 - 1943.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society